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Résumé en
anglais
Methoxetamine (MXE; 2-(3-methoxyphenyl)-2-(N-ethylamino)-cyclohexanone), a
ketamine analog, is a new designer drug and synthesized for its longer lasting and
favorable pharmacological effects over ketamine. The aims of the presented study
were to identify the phases I and II metabolites of MXE in rat and human urine by
GC-MS and LC-high-resolution (HR)-MS n and to evaluate their detectability by GC-
MS and LC-MSn using authors’ standard urine screening approaches (SUSAs).
Furthermore, human cytochrome P450 (CYP) enzymes were identified to be involved
in the initial metabolic steps of MXE in vitro, and respective enzyme kinetic studies
using the metabolite formation and substrate depletion approach were conducted.
Finally, human urine samples from forensic cases, where the ingestion of MXE was
suspected, were analyzed. Eight metabolites were identified in rat and different
human urines allowing postulation of the following metabolic pathways: N-
deethylation, O-demethylation, hydroxylation, and combinations as well as
glucuronidation or sulfation. The enzyme kinetic studies showed that the initial
metabolic step in humans, the N-deethylation, was catalyzed by CYP2B6 and
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